SCHEMBL1016584

SCHEMBL1016584

COC(=O)c1cc(Cl)ccc1NC(=O)COCC(=O)Nc1cc(-c2cccc(OC)c2)ccc1C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
LMNA P02545 4/20 0.50
MAPT P10636 2/20 0.49
PKM P14618 1/20 0.49
HTT P42858 1/20 0.49
SERPINE1 P05121 2/20 0.48
KDM4E B2RXH2 3/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
L3MBTL1 Q9Y468 2/20 0.45
THRB P10828 1/20 0.44
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
GAA P10253 1/20 0.44
HCAR2 Q8TDS4 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013571 0.92 SERPINE1 (0.57) ALDH1A1LMNAMAPTPKMHTT
SCHEMBL1014695 0.91 ALDH1A1 (0.53) ALDH1A1LMNAMAPTKDM4ECYP1A2
SCHEMBL1015997 0.87 ALDH1A1 (0.48) ALDH1A1LMNAMAPTPKMHTT
SCHEMBL1013557 0.86 ALDH1A1 (0.54) ALDH1A1LMNAMAPTKDM4ESMN1; SMN2
SCHEMBL1015634 0.85 ALDH1A1 (0.53) ALDH1A1LMNAMAPTKDM4ESMN1; SMN2
SCHEMBL1013814 0.85 GAA (0.52) ALDH1A1LMNAMAPTHTTKDM4E
SCHEMBL1015866 0.83 ALDH1A1 (0.51) ALDH1A1LMNAMAPTKDM4ESMN1; SMN2
SCHEMBL1015322 0.83 ALDH1A1 (0.54) ALDH1A1LMNAMAPTPKMSERPINE1
SCHEMBL1015109 0.83 SERPINE1 (0.57) ALDH1A1LMNASERPINE1KDM4ESMN1; SMN2
SCHEMBL1016695 0.81 LMNA (0.51) ALDH1A1LMNAMAPTKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 ALDH1A1 888/4885LMNA 525/4885MAPT 3139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.